Amylyx has presented new exploratory analyses from the Phase II PREVENT and Phase IIb trials of avexitide for PBH treatment.

Crinetics Pharmaceuticals has revealed new data from its clinical development programme for Palsonify, an oral treatment for acromegaly.

Takeda’s oral narcolepsy drug, oveporexton, has met the primary and secondary endpoints in two Phase III trials. The FirstLight (NCT06470828) and RadiantLight (NCT06505031) trials both met all their ...

The study assessed avutometinib alone and in conjunction with defactinib in those with recurrent low-grade serous ovarian cancer. Credit: Jo Panuwat D/Shutterstock. Verastem Oncology has reported ...